1150 related articles for article (PubMed ID: 34061203)
1. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL
JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203
[TBL] [Abstract][Full Text] [Related]
2. The Joint Impact of COVID-19 Vaccination and Non-Pharmaceutical Interventions on Infections, Hospitalizations, and Mortality: An Agent-Based Simulation.
Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Swann JL
medRxiv; 2021 Jan; ():. PubMed ID: 33442712
[TBL] [Abstract][Full Text] [Related]
3. Model-Estimated Association Between Simulated US Elementary School-Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels.
Giardina J; Bilinski A; Fitzpatrick MC; Kendall EA; Linas BP; Salomon J; Ciaranello AL
JAMA Netw Open; 2022 Feb; 5(2):e2147827. PubMed ID: 35157056
[TBL] [Abstract][Full Text] [Related]
4. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
[TBL] [Abstract][Full Text] [Related]
5. Simulated Identification of Silent COVID-19 Infections Among Children and Estimated Future Infection Rates With Vaccination.
Moghadas SM; Fitzpatrick MC; Shoukat A; Zhang K; Galvani AP
JAMA Netw Open; 2021 Apr; 4(4):e217097. PubMed ID: 33890990
[TBL] [Abstract][Full Text] [Related]
6. Mathematical modelling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada.
Aruffo E; Yuan P; Tan Y; Gatov E; Moyles I; Bélair J; Watmough J; Collier S; Arino J; Zhu H
BMC Public Health; 2022 Jul; 22(1):1349. PubMed ID: 35841012
[TBL] [Abstract][Full Text] [Related]
7. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
[TBL] [Abstract][Full Text] [Related]
8. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.
Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM
BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429
[TBL] [Abstract][Full Text] [Related]
9. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
[TBL] [Abstract][Full Text] [Related]
10. Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021.
Borchering RK; Viboud C; Howerton E; Smith CP; Truelove S; Runge MC; Reich NG; Contamin L; Levander J; Salerno J; van Panhuis W; Kinsey M; Tallaksen K; Obrecht RF; Asher L; Costello C; Kelbaugh M; Wilson S; Shin L; Gallagher ME; Mullany LC; Rainwater-Lovett K; Lemaitre JC; Dent J; Grantz KH; Kaminsky J; Lauer SA; Lee EC; Meredith HR; Perez-Saez J; Keegan LT; Karlen D; Chinazzi M; Davis JT; Mu K; Xiong X; Pastore Y Piontti A; Vespignani A; Srivastava A; Porebski P; Venkatramanan S; Adiga A; Lewis B; Klahn B; Outten J; Schlitt J; Corbett P; Telionis PA; Wang L; Peddireddy AS; Hurt B; Chen J; Vullikanti A; Marathe M; Healy JM; Slayton RB; Biggerstaff M; Johansson MA; Shea K; Lessler J
MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):719-724. PubMed ID: 33988185
[TBL] [Abstract][Full Text] [Related]
11. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19.
Pan J; Zhu W; Tian J; Liu Z; Xu A; Yao Y; Wang W
Infect Dis Poverty; 2022 Mar; 11(1):36. PubMed ID: 35346382
[TBL] [Abstract][Full Text] [Related]
12. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
[TBL] [Abstract][Full Text] [Related]
13. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies.
Ryckman T; Chin ET; Prince L; Leidner D; Long E; Studdert DM; Salomon JA; Alarid-Escudero F; Andrews JR; Goldhaber-Fiebert JD
Lancet Public Health; 2021 Oct; 6(10):e760-e770. PubMed ID: 34364404
[TBL] [Abstract][Full Text] [Related]
14. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
[TBL] [Abstract][Full Text] [Related]
15. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
Milne GJ; Carrivick J; Whyatt D
BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
[TBL] [Abstract][Full Text] [Related]
16. Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US.
Flaxman AD; Issema R; Barnabas RV; Ross JM
JAMA Netw Open; 2022 Apr; 5(4):e228632. PubMed ID: 35452104
[TBL] [Abstract][Full Text] [Related]
17. Analysis of COVID-19 Risk Following a Ring Vaccination Intervention to Address SARS-CoV-2 Alpha Variant Transmission in Montreal, Canada.
Périnet S; Cadieux G; Mercure SA; Drouin M; Allard R
JAMA Netw Open; 2022 Feb; 5(2):e2147042. PubMed ID: 35147688
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact.
Swan DA; Bracis C; Janes H; Moore M; Matrajt L; Reeves DB; Burns E; Donnell D; Cohen MS; Schiffer JT; Dimitrov D
Sci Rep; 2021 Jul; 11(1):15531. PubMed ID: 34330945
[TBL] [Abstract][Full Text] [Related]
19. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
[TBL] [Abstract][Full Text] [Related]
20. Controlling the pandemic during the SARS-CoV-2 vaccination rollout.
Viana J; van Dorp CH; Nunes A; Gomes MC; van Boven M; Kretzschmar ME; Veldhoen M; Rozhnova G
Nat Commun; 2021 Jun; 12(1):3674. PubMed ID: 34135335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
